Glenmede Trust’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-8,071
| Closed | -$209K | – | 1211 |
|
|
2020
Q4 | $209K | Sell |
8,071
-4,120
| -34% | -$107K | ﹤0.01% | 1048 |
|
|
2020
Q3 | $453K | Buy |
12,191
+3,060
| +34% | +$114K | ﹤0.01% | 817 |
|
|
2020
Q2 | $468K | Sell |
9,131
-1,065
| -10% | -$54.6K | ﹤0.01% | 779 |
|
|
2020
Q1 | $607K | Hold |
10,196
| – | – | ﹤0.01% | 852 |
|
|
2019
Q4 | $607K | Buy |
+10,196
| New | +$607K | ﹤0.01% | 852 |
|
|
2016
Q3 | – | Sell |
-500
| Closed | -$4K | – | 2606 |
|
|
2016
Q2 | $4K | Buy |
+500
| New | +$4K | ﹤0.01% | 2275 |
|